COJOCARU, S., RUSSU, I., BUTA, G., BERSAN, S., POTÎNG-RAȘCOV, V., CULIUC, N. and BABA, L. (2023) “A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease”, One Health & Risk Management , 4(4), pp. 19-26. doi: 10.38045/ohrm.2023.4.02.